Search
for
Sort by
Research 721–750 of 1000+
- MCMV Infection Lowers the Threshold for the Development of Clinical GvHD after Allogeneic Bone Marrow Transplantation.
- Androgens in SARS-CoV-2 Coronavirus Infections
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- An Uncommon and Severe Clinical Case of Sarcoptes scabiei Infestation in a Cat
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Case Report: Alopecia areata in an adolescent after COVID-19 infection
- Drug Repurposing Patent Applications July–September 2025
- Dermatological Manifestations of COVID-19 Patients
- Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation.
- Dermatological Manifestations of COVID-19: A Brief Review
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
- News in brief
- Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States
- Role of ACE2 polymorphism in COVID-19: impact of age
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Skin amidst COVID ‐19 pandemic
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Viva questions from the IJDVL
- COVID-19 infection leading to acute pustular dermatoses